FocusTherapeutics Discovery

Type 1 Diabetes Immunotherapy: Is the Glass Half Empty or Half Full?

Science Translational Medicine  10 Aug 2011:
Vol. 3, Issue 95, pp. 95fs1
DOI: 10.1126/scitranslmed.3002981

You are currently viewing the abstract.

View Full Text

Log in


Abstract

Reevaluation of clinical data from the recent failed immunotherapy trials suggests that researchers should continue the quest to cure type 1 diabetes with immune therapies.

Footnotes

  • Citation: K. C. Herold, J. A. Bluestone, Type 1 Diabetes Immunotherapy: Is the Glass Half Empty or Half Full? Sci. Transl. Med. 3, 95fs1 (2011).

View Full Text